… available regarding the treatment efficacy or adverse effects. … one retrospective) after detailed
screening from 909 relevant … compared with chemotherapy alone with much less adverse …

… We retrospectively evaluated the efficacy of erlotinib and … Sex, smoking and histology had
non-significant differences in … of patients in our limited clinical trial, our retrospective study is …

… efficacy in recurrent metastatic non-small-cell lung cancer (NSCLC… We conducted a
retrospective review of NSCLC patient … with second-line erlotinib therapy as compared with male …

… Cancer Center were identified, and a retrospective review of … , best overall tumor response,
erlotinib-related adverse events, … significant differences between the effects of erlotinib in PR …

… with erlotinib compared with placebo (24% versus 5%; p = 0.0025). … We report results of a
retrospective subanalysis of efficacy … Adverse events (AEs) and serious AEs were classified …

… We retrospectively analyzed the clinical data of 102 patients … adverse reaction rate compared
with Gefitinib treatment. … improve the clinical efficacy of non-small cell lung cancer. However…

… compared with non-Asian patients. We report safety and … Multiple retrospective studies from
Asia report high response … permitted in the event of treatment-related adverse events (AEs). …

… adverse events (AE), occurrence of adverse events of grade 3 or above (≥3AE), and occurrence
of serious adverse events (… , p < 0.05 in all cases compared with Ch alone). The highest-…

… adverse events (AEs). … compared to erlotinib for advanced NSCLC, which did not respond
to standard first-line chemotherapy (40). A retrospective study revealed that erlotinib/gefitinib …

… risk of grade 3 adverse events, compared to the other EGFR-… better efficacy than and
reduced the risk of CNS progression … A retrospective analysis of osimertinib combined with …